{
    "organizations": [],
    "uuid": "01f017fcfd02e0be5f86abf1bbb0c99e4bb121e4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangdong-jiaying-to-buy-stake-in/brief-guangdong-jiaying-to-buy-stake-in-guiyang-pharma-firm-for-at-least-500-mln-yuan-idUSH9N1Q201F",
    "ord_in_thread": 0,
    "title": "BRIEF-Guangdong Jiaying To Buy Stake In Guiyang Pharma Firm For At Least 500 Mln Yuan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Guangdong Jiaying Pharmaceutical Co Ltd :\n* SAYS IT PLANS TO BUY 99.7 PERCENT STAKE IN GUIYANG DECHANG XIANG PHARMACEUTICAL CO FOR AT LEAST 500 MILLION YUAN ($78.78 million) VIA CASH, SHARE PRIVATE PLACEMENT\n* SAYS IT AIMS TO DISCLOSE THE ASSET RESTRUCTURING PROPOSAL BEFORE MARCH 22 Source text in Chinese: bit.ly/2HAJlhx Further company coverage: ($1 = 6.3468 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-02-22T12:17:00.000+02:00",
    "crawled": "2018-02-22T18:08:57.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "guangdong",
        "jiaying",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "plan",
        "buy",
        "percent",
        "stake",
        "guiyang",
        "dechang",
        "xiang",
        "pharmaceutical",
        "co",
        "least",
        "million",
        "yuan",
        "million",
        "via",
        "cash",
        "share",
        "private",
        "placement",
        "say",
        "aim",
        "disclose",
        "asset",
        "restructuring",
        "proposal",
        "march",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}